{"id":"https://openalex.org/W2130146067","doi":"https://doi.org/10.1128/aac.49.10.4372-4374.2005","title":"Comparative In Vitro Activity of Ceftobiprole against Staphylococci Displaying Normal and Small-Colony Variant Phenotypes","display_name":"Comparative In Vitro Activity of Ceftobiprole against Staphylococci Displaying Normal and Small-Colony Variant Phenotypes","alternate_titles":[],"publication_year":2005,"publication_date":"2005-09-27","ids":{"openalex":"https://openalex.org/W2130146067","doi":"https://doi.org/10.1128/aac.49.10.4372-4374.2005","mag":"2130146067","pmid":"https://pubmed.ncbi.nlm.nih.gov/16189125","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1251552"},"language":"en","primary_location":{"id":"doi:10.1128/aac.49.10.4372-4374.2005","doi":"https://doi.org/10.1128/aac.49.10.4372-4374.2005","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.49.10.4372-4374.2005","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2130146067"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC1251552","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109129933","display_name":"Christof von Eiff","orcid":"https://orcid.org/0000-0002-7821-2359","observed_orcids":["https://orcid.org/0000-0002-7821-2359"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Christof von Eiff","raw_affiliation_strings":["Institute of Medical Microbiology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medical Microbiology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101591615","display_name":"Alexander W. Friedrich","orcid":"https://orcid.org/0000-0002-8281-6489","observed_orcids":["https://orcid.org/0000-0002-8281-6489"]},"institutions":[{"id":"https://openalex.org/I4210103666","display_name":"University Hospital M\u00fcnster","ror":"https://ror.org/01856cw59","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210103666"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexander W. Friedrich","raw_affiliation_strings":["Institute of Hygiene, University of Mu\u0308nster Hospital and Clinics, 48149 Mu\u0308nster, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Hygiene, University of Mu\u0308nster Hospital and Clinics, 48149 Mu\u0308nster, Germany","institution_ids":["https://openalex.org/I4210103666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070963176","display_name":"Karsten Becker","orcid":"https://orcid.org/0000-0002-6391-1341","observed_orcids":["https://orcid.org/0000-0002-6391-1341"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karsten Becker","raw_affiliation_strings":["Institute of Medical Microbiology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medical Microbiology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026896969","display_name":"Georg Peters","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Georg Peters","raw_affiliation_strings":["Institute of Medical Microbiology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medical Microbiology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109129933"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.5228,"has_fulltext":false,"cited_by_count":56,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92249442,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"49","issue":"10","first_page":"4372","last_page":"4374"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceftobiprole","display_name":"ceftobiprole","score":1.0},{"id":"https://openalex.org/keywords/staphylococcus-aureus","display_name":"Staphylococcus aureus","score":0.9729999899864197},{"id":"https://openalex.org/keywords/small-colony-variants","display_name":"small colony variants","score":0.8769999742507935},{"id":"https://openalex.org/keywords/antistaphylococcal-activity","display_name":"antistaphylococcal activity","score":0.9169999957084656},{"id":"https://openalex.org/keywords/cefuroxime","display_name":"cefuroxime","score":0.9359999895095825},{"id":"https://openalex.org/keywords/linezolid","display_name":"linezolid","score":1.0},{"id":"https://openalex.org/keywords/moxifloxacin","display_name":"moxifloxacin","score":1.0},{"id":"https://openalex.org/keywords/beta-lactam-antibiotics","display_name":"beta-lactam antibiotics","score":0.7860000133514404},{"id":"https://openalex.org/keywords/antibiotic-susceptibility","display_name":"antibiotic susceptibility","score":0.39800000190734863}],"concepts":[{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.8857704401016235},{"id":"https://openalex.org/C2780493024","wikidata":"https://www.wikidata.org/wiki/Q19903202","display_name":"Agar dilution","level":4,"score":0.8367902040481567},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6991397142410278},{"id":"https://openalex.org/C2778836808","wikidata":"https://www.wikidata.org/wiki/Q424940","display_name":"Moxifloxacin","level":3,"score":0.656917929649353},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.6195586919784546},{"id":"https://openalex.org/C2909292399","wikidata":"https://www.wikidata.org/wiki/Q19903202","display_name":"Agar Dilution Method","level":4,"score":0.48437556624412537},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.46853891015052795},{"id":"https://openalex.org/C176947019","wikidata":"https://www.wikidata.org/wiki/Q597889","display_name":"Minimum inhibitory concentration","level":3,"score":0.4527471661567688},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.449780136346817},{"id":"https://openalex.org/C2777514703","wikidata":"https://www.wikidata.org/wiki/Q413728","display_name":"Cefuroxime","level":3,"score":0.4291412830352783},{"id":"https://openalex.org/C2778660310","wikidata":"https://www.wikidata.org/wiki/Q177998","display_name":"Agar","level":3,"score":0.42746978998184204},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.40462347865104675},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38700979948043823},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.37958386540412903},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.24251574277877808},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08700412511825562}],"mesh":[{"descriptor_ui":"D000069349","descriptor_name":"Linezolid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077266","descriptor_name":"Moxifloxacin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001372","descriptor_name":"Aza Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002444","descriptor_name":"Cefuroxime","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D013210","descriptor_name":"Staphylococcus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013210","descriptor_name":"Staphylococcus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013210","descriptor_name":"Staphylococcus","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D014644","descriptor_name":"Genetic Variation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D024841","descriptor_name":"Fluoroquinolones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1128/aac.49.10.4372-4374.2005","doi":"https://doi.org/10.1128/aac.49.10.4372-4374.2005","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.49.10.4372-4374.2005","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:168872","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1251552","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:1251552","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1251552/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:16189125","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16189125","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/5f732a7f-7edc-4ad6-a1be-c8758758d324","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/5f732a7f-7edc-4ad6-a1be-c8758758d324","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"von Eiff, C, Friedrich, A W, Becker, K & Peters, G 2005, 'Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes', Antimicrobial Agents and Chemotherapy, vol. 49, no. 10, pp. 4372-4374. https://doi.org/10.1128/AAC.49.10.4372-4374.2005","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/5f732a7f-7edc-4ad6-a1be-c8758758d324","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/5f732a7f-7edc-4ad6-a1be-c8758758d324","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antimicrobial Agents and Chemotherapy, 49(10), 4372 - 4374. AMER SOC MICROBIOLOGY","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:168872","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1251552","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W296417594","https://openalex.org/W972893176","https://openalex.org/W1916238341","https://openalex.org/W1955612312","https://openalex.org/W1975789761","https://openalex.org/W2005955658","https://openalex.org/W2018406369","https://openalex.org/W2040996451","https://openalex.org/W2067868132","https://openalex.org/W2081183044","https://openalex.org/W2082267277","https://openalex.org/W2088960594","https://openalex.org/W2089388387","https://openalex.org/W2090986887","https://openalex.org/W2108013032","https://openalex.org/W2112967578","https://openalex.org/W2114660268","https://openalex.org/W2129898726","https://openalex.org/W2137448773","https://openalex.org/W2138699870","https://openalex.org/W2143892743","https://openalex.org/W2146196411","https://openalex.org/W2149599780","https://openalex.org/W2150990827","https://openalex.org/W2151124149","https://openalex.org/W2151722492","https://openalex.org/W2152366242","https://openalex.org/W2156726015","https://openalex.org/W2159366663","https://openalex.org/W2162693439"],"related_works":["https://openalex.org/W3094084101","https://openalex.org/W1987270289","https://openalex.org/W2128053708","https://openalex.org/W2031488964","https://openalex.org/W7062933627","https://openalex.org/W4408143261","https://openalex.org/W1973744390","https://openalex.org/W4310297354","https://openalex.org/W2039143390","https://openalex.org/W2188446519"],"abstract_inverted_index":{"The":[0],"antistaphylococcal":[1,47],"activity":[2],"of":[3,9,40,52],"ceftobiprole":[4],"was":[5],"compared":[6],"with":[7,24],"those":[8],"cefuroxime,":[10],"linezolid,":[11],"and":[12],"moxifloxacin":[13],"by":[14,35],"using":[15],"the":[16],"agar":[17],"dilution":[18],"method.":[19],"Apart":[20],"from":[21],"three":[22],"strains":[23],"small-colony":[25],"variant":[26],"phenotypes,":[27],"all":[28],"Staphylococcus":[29],"aureus":[30],"isolates":[31],"tested":[32],"were":[33],"inhibited":[34],"<":[36],"or":[37],"=2":[38],"microg/ml":[39],"ceftobiprole.":[41],"This":[42],"compound":[43],"exhibited":[44],"an":[45],"excellent":[46],"activity,":[48],"comparable":[49],"to":[50],"that":[51],"linezolid.":[53]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2130146067","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
